Aardvark Therapeutics (AARD) EPS (Basic) (2024 - 2026)
Aardvark Therapeutics (AARD) posted EPS (Basic) of -$0.99 for Q1 2026, down 10.4% sequentially from -$0.9 in Q4 2025, and down 40.37% YoY from -$1.66 in Q1 2025.
Aardvark Therapeutics (AARD) EPS (Basic) (2024 - 2026) Analysis & Trends
Aardvark Therapeutics has reported EPS (Basic) for 3 years, with the latest figure at -$0.99 in Q1 2026.
- Quarterly EPS (Basic) fell 40.37% year-over-year to -$0.99 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.2 (down 37.34% YoY) and the FY2025 annual result came in at -$3.56, up 63.3% from the prior year.
- EPS (Basic) eased to -$0.99 in Q1 2026 per AARD's latest filing, from -$0.9 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.52 in Q1 2024 and troughed at -$2.98 in Q4 2024.
- A 3-year average of -$1.1 and a median of -$0.9 in 2025 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2025 and 2026: EPS (Basic) soared 69.94% in 2025, then tumbled 40.37% in 2026.
- Over 3 years, EPS (Basic) stood at -$2.98 in 2024, then soared by 69.94% to -$0.9 in 2025, then dropped by 10.4% to -$0.99 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.99, -$0.9, and -$0.75 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.53 Bn | 130.68 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.34 Bn | 78.35 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.67 Bn | 59.48 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 59.04 Bn | 53.90 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.03 Bn | 36.94 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.78 Bn | 27.47 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 27.81 Bn | 9.42 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.21 Bn | 26.05 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 26.99 Bn | 26.15 Bn | - | 0.18 |
| 10 | Aardvark Therapeutics | 132.83 Mn | 58.90 Mn | - | -0.66 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.66 |
| Mar 31, 2026 | -0.99 |
| Dec 31, 2025 | -0.90 |
| Sep 30, 2025 | -0.75 |
| Jun 30, 2025 | -0.66 |
| Mar 31, 2025 | -0.70 |
| Dec 31, 2024 | -2.98 |
| Sep 30, 2024 | -1.03 |
| Jun 30, 2024 | -1.38 |
| Mar 31, 2024 | -0.52 |